These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9662203)

  • 41. Role of the primary infection in epidemics of HIV infection in gay cohorts.
    Jacquez JA; Koopman JS; Simon CP; Longini IM
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1169-84. PubMed ID: 7932084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New preventive vaccine study.
    Bowers M
    BETA; 1996 Mar; ():5. PubMed ID: 11363320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.
    Boily MC; Abu-Raddad L; Desai K; Masse B; Self S; Anderson R
    Lancet Infect Dis; 2008 Mar; 8(3):200-7. PubMed ID: 18291341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simulating the effect of vaccine-induced immune responses on HIV infection.
    Guardiola J; Izzo G; Vecchio A
    Hum Immunol; 2003 Sep; 64(9):840-51. PubMed ID: 12941538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AIDS vaccine blueprint launched: a challenge to the field.
    McEnery R
    IAVI Rep; 2008; 12(4):15. PubMed ID: 20213990
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological impact of social disruption resulting from epidemic disease.
    McGrath JW
    Am J Phys Anthropol; 1991 Apr; 84(4):407-19. PubMed ID: 2053615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential population health outcomes and expenditures of HIV vaccination strategies in the United States.
    Long EF; Brandeau ML; Owens DK
    Vaccine; 2009 Aug; 27(39):5402-10. PubMed ID: 19591796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark, Norway and Sweden.
    Amundsen EJ; Stigum H; Røttingen JA; Aalen OO
    Epidemiol Infect; 2004 Dec; 132(6):1139-49. PubMed ID: 15635973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemic prediction and control in clustered populations.
    House T; Keeling MJ
    J Theor Biol; 2011 Mar; 272(1):1-7. PubMed ID: 21147131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A stochastic model of the HIV epidemic and the HIV infection distribution in a homosexual population.
    Tan WY; Byers RH
    Math Biosci; 1993 Jan; 113(1):115-43. PubMed ID: 8431645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards an AIDS vaccine: challenges and prospects.
    Homsy J; Steimer K; Kaslow R
    Immunol Today; 1987; 8(7-8):193-6. PubMed ID: 25290421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 Preventive vaccines: an attainable goal?
    Girard MP; Paul S; Verrier B
    Virologie (Montrouge); 2013 Jun; 17(3):193-205. PubMed ID: 31910546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Traditional approach preventive HIV vaccines: What are the cell substrate and inactivation issues?
    Sheets RL; Goldenthal KL
    AIDS Res Hum Retroviruses; 1998 May; 14(7):627-33. PubMed ID: 9591717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.
    Harmon T; Guo W; Stover J; Wu Z; Kaufman J; Schneider K; Liu L; Feng L; Schwartländer B
    Vaccines (Basel); 2015 Jan; 3(1):1-19. PubMed ID: 26344945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovering an epidemic before it has reached a certain level of prevalence.
    Metz JA; Wedel M; Angulo AF
    Biometrics; 1983 Sep; 39(3):765-70. PubMed ID: 6360226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    Matter D; Potgieter L
    PLoS One; 2021; 16(3):e0248053. PubMed ID: 33667263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic equilibria in an epidemic model with voluntary vaccinations.
    Chen FH; Cottrell A
    J Biol Dyn; 2009 Jul; 3(4):357-75. PubMed ID: 22876938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS: modeling epidemic control.
    Rida W; Fast P; Hoff R; Barker L
    Science; 1995 Mar; 267(5202):1251-2; author reply 1252-3. PubMed ID: 7871415
    [No Abstract]   [Full Text] [Related]  

  • 59. Vaccine preparedness: lessons from Lyantonde, Uganda.
    Ritvo P; Willms D; Meisner R; Brown L; Goldman A; Sewankambo N
    Afr J AIDS Res; 2006 May; 5(1):11-6. PubMed ID: 25875142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tennessee Nurses Association. Resolution. In support of HIV/AIDS preventive vaccine research.
    Tenn Nurse; 1996 Dec; 59(6):13, 18. PubMed ID: 9025630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.